Korean J Ophthalmol.  2015 Apr;29(2):143-145. 10.3341/kjo.2015.29.2.143.

Massive Exudative Retinal Detachment Following Photodynamic Therapy and Intravitreal Bevacizumab Injection in Retinal Capillary Hemangioma

Affiliations
  • 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. sejoon1@snu.ac.kr

Abstract

No abstract available.


MeSH Terms

Angiogenesis Inhibitors/administration & dosage/adverse effects
Bevacizumab/administration & dosage/*adverse effects
Follow-Up Studies
Hemangioma, Capillary/diagnosis/*drug therapy
Humans
Intravitreal Injections
Male
Photochemotherapy/*adverse effects
Retina/*pathology
Retinal Detachment/*chemically induced/diagnosis
Retinal Neoplasms/diagnosis/*drug therapy
Time Factors
Young Adult
Angiogenesis Inhibitors
Bevacizumab

Figure

  • Fig. 1 Fundus photographs of the left eye of our 24-year-old patient with confirmed von Hippel-Lindau disease obtained at the initial visit (A) and two years later (B). A peripheral retinal capillary hemangioma with dilated feeder vessels was observed. A fundus fluorescence angiography image (C) revealed leakage from the hemangioma, and optical coherence tomography (OCT) showed shallow subretinal fluid (D). Fourteen days after photodynamic therapy combined with an intravitreal injection of bevacizumab, fundus photography (E) and ultrasonography (F) revealed massive exudative retinal detachment with retinal hemorrhage. Two months after pars plana vitrectomy with silicone oil tamponade, fundus photography (G) and OCT (H) showed that the retina had reattached, and the subretinal fluid had disappeared. One year after silicone oil removal, fundus photography (I) and OCT (J) showed no retinal capillary hemangioma recurrence or subretinal exudation.


Cited by  1 articles

Clinical Results of Various Treatments for Retinal Capillary Hemangioma
Yeo-Kyoung Won, Min-Woo Lee, Yong-Il Shin, Jung-Yeul Kim, Young-Joon Jo
Korean J Ophthalmol. 2020;34(2):133-142.    doi: 10.3341/kjo.2019.0075.


Reference

1. Mennel S, Meyer CH, Callizo J. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma. Acta Ophthalmol. 2010; 88:610–613.
2. Wong YM, Jalil A, Mathews J, Stanga PE. Exudative retinal detachment following photodynamic therapy for retinal capillary hemangioma. Can J Ophthalmol. 2010; 45:299–300.
3. Goto S, Oshima Y, Tsujikawa M, Nishida K. Massive exudative retinal detachment after photodynamic therapy for peripheral retinal capillary hemangioma. Retin Cases Brief Rep. 2013; 7:86–88.
4. Chen Y, Liu H, Zhang K, Gao L. Massive exudative retinal detachment following photodynamic therapy for retinal hemangioma in von Hippel-Lindau Syndrome. Photodiagnosis Photodyn Ther. 2014; 11:250–253.
5. Papastefanou VP, Pilli S, Stinghe A, et al. Photodynamic therapy for retinal capillary hemangioma. Eye (Lond). 2013; 27:438–442.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr